Get the Daily Brief
Latest Biotech News
Scipher Medicine Shifts Toward Data-Driven Precision Medicine
Scipher Medicine, traditionally focused on diagnostics for rheumatoid arthritis, is pivoting toward leveraging its extensive transcriptomic datasets to drive precision medicine beyond oncology....
FDA Regulatory Setbacks and Clinical Updates in Biopharma
Recent regulatory and clinical developments include the FDA advisory committee voting against approval of Otsuka’s Rexulti-Zoloft combo for PTSD due to insufficient Phase 3 data, and the FDA...
Gene Therapy Safety Under Scrutiny: Lessons From Sarepta Deaths
The recent deaths in Sarepta’s gene therapy trials have reignited debates reminiscent of the Jesse Gelsinger incident about safety oversight in gene therapy. Industry experts and patient advocates...
Boston Area Expands Biomanufacturing Capacity with GenesisM Facility
GenesisM has initiated construction of a 154,000-square-foot, Class A biomanufacturing facility in Bedford, MA, reinforcing Boston's status as a leading biopharma cluster. The multi-tenant suite...
Neuralink Valued at $9 Billion Despite Small Disadvantaged Business Filing
Neuralink, Elon Musk’s brain-computer interface company, recently filed as a 'small disadvantaged business' with the U.S. Small Business Administration, a status that can offer federal procurement...
Innovative Biotechnology: Engineered Bacteria Create Milk Proteins for Vegan Products
Scientists have engineered Escherichia coli bacteria to produce key milk proteins essential for authentic cheese and yogurt, eliminating the need for cows in dairy production. This breakthrough...
Advanced Multiplexing Reveals Kidney Disease Mechanisms
Researchers have introduced PathoPlex, a multiplex pathology technology enabling spatially resolved, high-dimensional imaging to map immune-mediated kidney disease at cellular and molecular...
Machine Learning Deciphers Sorghum Mold Resistance Genetics
In an effort to safeguard global food security, researchers employed machine learning techniques to untangle the complex genetic basis of sorghum grain mold resistance. This work addresses a...
Multiomic Biomarker Research Gets Boost with €2.5M Grant in Vienna
The Medical University of Vienna's Core Facilities secured €2.5 million from the Austrian Research Promotion Agency to advance multiomics-based biomarker discovery and validation. The funding...
Sarepta's Gene Therapy Deaths and FDA Confrontation
Sarepta Therapeutics faces a crisis following the deaths of three patients linked to its gene therapies for Duchenne muscular dystrophy and limb-girdle muscular dystrophy. The fatalities, caused...
Scipher Medicine Expands into Precision Medicine
Scipher Medicine is pivoting from solely providing molecular diagnostics for rheumatoid arthritis to advancing data-driven precision medicine development across non-oncology diseases. Under CEO...
Biopharma Financing Trends and Facility Expansion
Biopharma financing remains robust in 2025 with notable increases in seed and Series A investments despite fewer contributing companies. GenesisM has initiated construction of a 154,000 sq ft...
FDA Regulatory Developments and Approval Activity
The FDA approved 22 drugs in June 2025, tying a recent high and contributing to a strong first-half performance with 107 total approvals. Key regulatory decisions include the agency’s rejection of...
Sarepta Gene Therapy Setbacks Stir Duchenne Community and Industry Debate
Recent deaths linked to Sarepta's gene therapies have profoundly affected families of Duchenne muscular dystrophy patients, who have embraced experimental treatments amid the disease's fatal...
Emerging Technologies in Biotech: AI, Quantum Computing, and Biomarkers
Cutting-edge advances are reshaping biotech discovery and diagnostics. David Baker's lab applies AI to understand elusive proteins, revealing new therapeutic targets. Concurrently, quantum...
Biopharma Trial Updates and Clinical Developments
June 2025 brought key clinical updates including FDA approvals of Gilead's twice-yearly HIV prevention shot and Nuvation Bio’s ROS1 inhibitor for lung cancer. Arvinas and Pfizer submitted their...
Biopharma Industry Workforce and Structural Changes
Workforce dynamics reveal industry strain and restructuring efforts. GSK is cutting 150 jobs in Massachusetts amid strategic shifts. Sail Biomedicines reduced staff by 30% and trimmed leadership...
Med-Tech IPO Activity and Regulatory Oversight
Heartflow Inc. filed an S-1 with the SEC on July 17, joining a wave of 15 med-tech companies with IPOs in 2025, underscoring ongoing investor interest in healthcare innovation technologies. The US...
Molecular Diagnostics Expansion and Global Market Entry
India’s Genes2Me prepares US expansion with regulatory submissions for sepsis and antimicrobial resistance assays on its OnePCR system, which supports a broad menu of molecular tests including...
Sarepta’s Duchenne Gene Therapy Halted Amid Safety Concerns
The FDA is preparing to halt shipments of Sarepta Therapeutics’ gene therapy Elevidys for Duchenne muscular dystrophy due to safety concerns following multiple patient deaths from acute liver...